Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

Subcutaneous ocrelizumab and hyaluronidase (Ocrevus Zunovo) was approved for relapsing and progressive multiple sclerosis, ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.

A study of 1.6 million brain cells revealed early cellular changes in Alzheimer's and intervention opportunities, using ...

While genetics play a role in early-onset Alzheimer's, environmental and lifestyle factors are also emerging as significant ...

New method uses patient-derived neurons to effectively simulate late-onset Alzheimer's and identify possible treatments. Researchers at Washington University School of Medicine in St. Louis have ...

Imagine a world where Alzheimer's disease could be effectively treated, not just managed. We might be one step closer to that ...

As the median age of our population rises, so does the number of people diagnosed with Alzheimer's disease. With advances in ...

An analysis of more than 1.6 million brain cells from older adults has captured the cellular changes that occur in the early stages of Alzheimer's disease, potentially revealing new routes for ...

Goodman and her colleagues found that even a 50 percent loss of healthy tau is sufficient to disrupt lipid droplets and ...

Boosting a specific protein in the brain could help slow the progression of Alzheimer’s disease, a new study has ... causing damage to neural cells and leading to cognitive decline.